Furthermore, tumours dramatically regressed in these mice leaving only medulloblastoma remnants in external position at 18 months (Fig. 5e), indicating that Otx2 ablation was sufficient to counteract SmoM2 mitogenic activity and long-term tumour maintenance. The gene discussed is OTX2; the disease is medulloblastoma.